Disturbances in humoral and cell-mediated immunity in rats with experimental depressive syndrome induced by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

被引:0
|
作者
Davydova, TV
Fomina, VG
Krupina, NA
Kryzhanovskii, GN
Evseev, VA
Orlova, IN
Iordanskaya, TE
机构
[1] RUSSIAN ACAD SCI,LAB NEUROIMMUNOPATHOL,MOSCOW 117901,RUSSIA
[2] RUSSIAN ACAD SCI,INST GEN PATHOL & PATHOPHYSIOL,LAB GEN PATHOL NERVOUS SYST,MOSCOW 117901,RUSSIA
基金
俄罗斯基础研究基金会;
关键词
depressive syndrome; MPTP; rats; T and B cells; immune complexes;
D O I
10.1007/BF02445422
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Changes in humoral and cell-mediated immunity are studied in rats with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced depressive syndrome. A decrease in the lymphocyte count and in absolute and relative T cell counts and absolute B cell counts in peripheral blood and an increase in serum concentration of circulating immune complexes (CIC) are demonstrated. Serum CIC content increases, while the relative count of peripheral blood T cells remains decreased two weeks after discontinuation of MPTP and normalization of rats' behavior. Serum CIC content decreases and T cell count normalizes one month after discontinuation of MPTP.
引用
收藏
页码:267 / 270
页数:4
相关论文
共 50 条
  • [11] REM sleep disorders in rats with experimental depressive syndrome caused by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
    N. A. Krupina
    G. N. Kryzhanovskii
    T. E. Iordanskaya
    N. B. Pankova
    I. N. Orlova
    Bulletin of Experimental Biology and Medicine, 1997, 123 : 116 - 120
  • [12] THE SIGNIFICANCE OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    MARSDEN, CD
    JENNER, PG
    CIBA FOUNDATION SYMPOSIA, 1987, 126 : 239 - 256
  • [13] IMMUNITY OF FETAL MICE TO PRENATAL ADMINISTRATION OF THE DOPAMINERGIC NEUROTOXIN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    MELAMED, E
    ROSENTHAL, J
    YOUDIM, MBH
    JOURNAL OF NEUROCHEMISTRY, 1990, 55 (04) : 1427 - 1431
  • [14] Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Ulanowska, K
    Wegrzyn, G
    JOURNAL OF APPLIED GENETICS, 2006, 47 (01) : 85 - 87
  • [15] Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
    Hare, Dominic J.
    Adlard, Paul A.
    Doble, Philip A.
    Finkelstein, David I.
    METALLOMICS, 2013, 5 (02) : 91 - 109
  • [16] Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Katarzyna Ulanowska
    Grzegorz Węgrzyn
    Journal of Applied Genetics, 2006, 47 : 85 - 87
  • [17] Involvement of calcium in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced experimental parkinsonism
    Samantaray, S
    Mohanakumar, KP
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 : 106 - 106
  • [18] BLADDER HYPERREFLEXIA INDUCED IN MARMOSETS BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    ALBANESE, A
    JENNER, P
    MARSDEN, CD
    STEPHENSON, JD
    NEUROSCIENCE LETTERS, 1988, 87 (1-2) : 46 - 50
  • [19] NICOTINE ENHANCES 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE NEUROTOXICITY
    BEHMAND, RA
    HARIK, SI
    JOURNAL OF NEUROCHEMISTRY, 1992, 58 (02) : 776 - 779
  • [20] Inactivation of acetylcholinesterase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride
    Lun-Yi Zang
    Hara P. Misra
    Molecular and Cellular Biochemistry, 2003, 254 : 131 - 136